ICU Medical, Inc.
ICUI
$128.18
$6.435.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.96% | 7.22% | 5.44% | 4.04% | 0.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.96% | 7.22% | 5.44% | 4.04% | 0.46% |
| Cost of Revenue | -2.18% | 3.04% | 2.50% | 4.31% | 0.52% |
| Gross Profit | 13.65% | 15.90% | 11.48% | 3.48% | 0.33% |
| SG&A Expenses | 2.86% | 4.34% | 5.29% | 6.64% | 3.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.71% | 3.40% | 3.32% | 4.88% | 1.27% |
| Operating Income | 214.95% | 257.94% | 103.62% | -25.77% | -31.46% |
| Income Before Tax | 116.17% | 60.51% | 15.69% | -75.87% | -24.48% |
| Income Tax Expenses | 291.74% | 226.39% | 206.23% | 100.28% | 9.68% |
| Earnings from Continuing Operations | 47.80% | -57.96% | -296.86% | -295.83% | -45.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.80% | -57.96% | -296.86% | -295.83% | -45.98% |
| EBIT | 214.95% | 257.94% | 103.62% | -25.77% | -31.46% |
| EBITDA | 24.75% | 27.53% | 14.57% | -7.13% | -7.11% |
| EPS Basic | 47.92% | -56.19% | -292.15% | -290.68% | -44.33% |
| Normalized Basic EPS | 138.07% | 117.87% | 76.47% | -75.64% | -122.87% |
| EPS Diluted | 47.54% | -56.62% | -292.64% | -290.49% | -44.37% |
| Normalized Diluted EPS | 138.10% | 117.90% | 76.42% | -76.30% | -122.45% |
| Average Basic Shares Outstanding | 1.27% | 1.34% | 1.23% | 1.02% | 0.94% |
| Average Diluted Shares Outstanding | 1.09% | 1.09% | 0.98% | 0.78% | 1.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |